model Industry Collaborative Research Agreement (mICRA)
The model Industry Collaborative Research Agreement is designed to support clinical research collaborations involving the pharmaceutical and biotechnology industries, academia and NHS organisations across the UK.
The model Agreement is supported by a comprehensive Guidance Document which sets out its background and aims and details how the Agreement should be used in the development of contracts for specific clinical research collaborations.
A Decision Tree is also available to guide users in identifying when studies are collaborative and whether mICRA is applicable. The Agreement has a choice of options for clauses covering Intellectual Property arrangements and the Decision Tree guides users through this process.
The model Industry Collaborative Research Agreement was developed by a working group led by the NIHR Office for Clinical Research Infrastructure (NOCRI) and the Medical Research Council. Representatives from industry, universities and the NHS, and the Intellectual Property Office, were brought together with expert legal opinion to develop a model Agreement that can be used to support all collaborative research scenarios. Organisations involved in the working group have agreed a Statement of Endorsement encouraging widespread use of the model Agreement to streamline the contracting process for collaborative research.
See press release for information on launch of mICRA
|mICRA Template contract
|| Word |
|mICRA Decision tree
|Statement of endorsement
Feedback on your experience of using this template agreement is welcomed and will be used to inform its future development. Please email any comments to firstname.lastname@example.org